Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed (2016 - 2025)

CorMedix (CRMD) has disclosed Return on Capital Employed for 12 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 11.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, up 11.0% year-over-year, with the annual reading at 0.11% for FY2025, N/A changed from the prior year.
  • Return on Capital Employed hit 0.05% in Q4 2025 for CorMedix, down from 0.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.4% in Q2 2025 to a low of 1.05% in Q2 2024.
  • Historically, Return on Capital Employed has averaged 0.38% across 5 years, with a median of 0.47% in 2022.
  • Biggest five-year swings in Return on Capital Employed: decreased -30bps in 2024 and later surged 145bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.44% in 2021, then decreased by -25bps to 0.55% in 2022, then fell by -14bps to 0.63% in 2023, then surged by 90bps to 0.06% in 2024, then surged by 181bps to 0.05% in 2025.
  • Business Quant data shows Return on Capital Employed for CRMD at 0.05% in Q4 2025, 0.33% in Q3 2025, and 0.4% in Q2 2025.